DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
D••••• P••••••••• L••
P•••••••••, Biotechnology & Life Sciencesgroup grade Aoff every schedule since Dec 31, 2024sponsor unattributed
Also written as: Biotechnology & Life Sciences; D••••• P••••••••• Holdings Ltd; P•••••••••
Nothing material in the last 200 days. Last change: 31 Dec 2024, Consensus mark 97¢ on cost, down from 102¢ in Q1 2024, 104¢ last quarter.
Mark path, consensus per quarter end
102¢ · 101¢ · 104¢ · 97¢Q1 2024 to Q4 2024
Principal held
at least $216M
sum of BDC pieces, a lower bound
Fair value
$223M
97c on cost, debt pieces
Unfunded
$57.8M
commitments not yet drawn
BDC lenders
3
3 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Jan 24, 2031
no dated debt inside 24 months
On the tape since
Mar 31, 2024
latest Dec 31, 2024
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| B••••••••• P•••••• C••••• F••• | $198M | 97¢ | -7 pts |
| F• K•• C•••••• C••• | $14M | 103¢ | +2 pts |
| B••••••••• S•••••• L•••••• F••• | $4.13M | 98¢ | -4 pts |
Every BDC piece · 20 positions across 3 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated N••••••••• I••••• | $97.8M | $101M 97c | S+625 bp |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated | $97.8M | $101M 97c | S+625 bp |
| F• K•• C•••••• C••• | unstated lien unstated | $3.7M | $3.7M 103c | S+625 bp |
| F• K•• C•••••• C••• | unstated lien unstated P•••••••••, B••••••••• & L••• S••••••• 1 | $3.7M | $3.7M 103c | S+625 bp |
| F• K•• C•••••• C••• | unstated lien unstated P•••••••••, B••••••••• & L••• S••••••• 2 | $3.3M | $3.5M 103c | S+625 bp |
View all 20 positionsShow fewerlargest principal first
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| F• K•• C•••••• C••• | unstated lien unstated | $3.3M | $3.5M 103c | S+625 bp |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated | $1.1M | $919,000 100c | S+625 bp |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated N••••••••• I••••• | $1.1M | $919,000 100c | S+625 bp |
| B••••••••• S•••••• L•••••• F••• | delayed draw term loan lien unstated | $1.0M | $1.0M 102c | S+625 bp |
| B••••••••• S•••••• L•••••• F••• | delayed draw term loan lien unstated N••••••••• I••••• | $1.0M | $1.0M 102c | S+625 bp |
| B••••••••• S•••••• L•••••• F••• | delayed draw term loan lien unstated | $1.0M | $1.1M 94c | S+625 bp |
| B••••••••• S•••••• L•••••• F••• | delayed draw term loan lien unstated N••••••••• I••••• | $1.0M | $1.1M 94c | S+625 bp |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated D•••••• D••• T••• L••• 1 | Not disclosed | Not disclosed | S+625 bp |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated D•••••• D••• T••• L••• 2 | Not disclosed | Not disclosed | S+625 bp |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated D•••••• D••• T••• L••• 2 | Not disclosed | Not disclosed | S+625 bp |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated D•••••• D••• T••• L••• 1 | Not disclosed | Not disclosed | S+625 bp |
| B••••••••• S•••••• L•••••• F••• | delayed draw term loan lien unstated D•••••• D••• T••• L••• 1 | Not disclosed | Not disclosed | S+625 bp |
| B••••••••• S•••••• L•••••• F••• | delayed draw term loan lien unstated D•••••• D••• T••• L••• 2 | Not disclosed | Not disclosed | S+625 bp |
| F• K•• C•••••• C••• | unstated lien unstated | Not disclosed | Not disclosed | |
| F• K•• C•••••• C••• | unstated lien unstated | Not disclosed | Not disclosed |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| delayed draw term loan lien unstated exited Dec 31, 2024 | at least $202M | 97c | S+625 bp | Jan 24, 2031 | 2 |
| other lien unstated exited Dec 31, 2024 | at least $14.0M | 103c | S+625 bp | Jan 24, 2031 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2024 | 3 | $216M | $223M | 97c | 0 |
| Sep 30, 2024 | 3 | $108M | $119M | 104c | 0 |
| Jun 30, 2024 | 3 | $137M | $145M | 101c | 0 |
| Mar 31, 2024 | 1 | $36.0M | $37.0M | 102c | 0 |
What changed
- Facility left every BDC scheduleDec 31, 2024
- Marked down (one lender)Dec 31, 2024
- Facility left every BDC scheduleDec 31, 2024
- New lender joined a facilityJun 30, 2024
- New lender joined a facilityJun 30, 2024
Full timeline · 6 eventsShow fewer
- New borrower on a BDC scheduleMar 31, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- D••••• P•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 3 BDCsderived
- Industry
- P•••••••••, Biotechnology & Life Sciencesreportedas one filer wrote it